These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1128 related items for PubMed ID: 25765966
21. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age. Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Vaccine; 2009 Apr 28; 27(19):2540-7. PubMed ID: 19124057 [Abstract] [Full Text] [Related]
25. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants. Tregnaghi M, Zambrano B, Santos-Lima E. Pediatr Infect Dis J; 2012 Jan 28; 31(1):e24-30. PubMed ID: 22157567 [Abstract] [Full Text] [Related]
29. Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity. Hesley TM, Reisinger KS, Sullivan BJ, Jensen EH, Stasiorowski S, Meechan C, Chan CY, West DJ, HIB-HB VACCINE STUDY GROUP. Pediatr Infect Dis J; 2004 Mar 28; 23(3):240-5. PubMed ID: 15014300 [Abstract] [Full Text] [Related]
30. Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age. Diaz-Mitoma F, Halperin SA, Tapiero B, Hoffenbach A, Zappacosta PS, Radley D, Bradshaw S, Martin JC, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Vaccine; 2011 Feb 01; 29(6):1324-31. PubMed ID: 21134456 [Abstract] [Full Text] [Related]
33. Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX. Shinefield HR, Black SB, Staehle BO, Adelman T, Ensor K, Ngai A, White CJ, Bird SR, Matthews H, Kuter BJ. Pediatr Infect Dis J; 1998 Nov 01; 17(11):980-5. PubMed ID: 9849978 [Abstract] [Full Text] [Related]
35. Infant vaccine co-administration: review of 18 years of experience with GSK's hexavalent vaccine co-administered with routine childhood vaccines. Dolhain J, Janssens W, Dindore V, Mihalyi A. Expert Rev Vaccines; 2020 May 01; 19(5):419-443. PubMed ID: 32419537 [Abstract] [Full Text] [Related]
36. A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children. Aquino AG, Brito MG, Doniz CE, Herrera JF, Macias M, Zambrano B, Plennevaux E, Santos-Lima E. Vaccine; 2012 Oct 05; 30(45):6492-500. PubMed ID: 22863658 [Abstract] [Full Text] [Related]
37. Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). Bernstein HH, Eves K, Campbell K, Black SB, Twiggs JD, Reisinger KS, Conti RM, Flodmark CE, Rombo L, Klopfer S, Schödel F, Hartzel J, Kuter BJ, Refrigerator-Stable Formulation Study Group for ProQuad. Pediatrics; 2007 Jun 05; 119(6):e1299-305. PubMed ID: 17502347 [Abstract] [Full Text] [Related]
38. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine. Gimenez-Sanchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Diez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, Liang JZ, Gruber WC, Emini EA, Scott DA, 501 and 006 study groups. Vaccine; 2011 Aug 11; 29(35):6042-8. PubMed ID: 21704105 [Abstract] [Full Text] [Related]
39. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study. Dhingra MS, Namazova-Baranova L, Arredondo-Garcia JL, Kim KH, Limkittikul K, Jantarabenjakul W, Perminova O, Kobashi IAR, Bae CW, Ojeda J, Park J, Chansinghakul D, B'Chir S, Neveu D, Bonaparte M, Jordanov E. Epidemiol Infect; 2021 Apr 05; 149():e90. PubMed ID: 33814028 [Abstract] [Full Text] [Related]
40. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ. Vaccine; 2006 May 29; 24(22):4727-36. PubMed ID: 16616973 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]